Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
2021
2021
2021
2021
2021
2022
Nate Davis is an Analyst on the Investment Team at RA Capital Management. Nate conducts due diligence on biotechnology companies at RA Capital and serves as a Board Director for The Covid Apollo Project and Nucleix. Previously, Nate worked closely with the Investment Team, as a Senior Associate within the TechAtlas division, to originate conviction in potential investments by identifying breakthroughs and putting data into context. Prior to RA Capital, Nate worked as an Investment Analyst at Wolfram Ventures. Nate has a BS in Biological Sciences from University of Vermont.
2019 - 2022
I am an Associate with the TechAtlas division of RA Capital Management. My primary responsibility is to create competitive landscapes of drugs and medical devices for disease indications and capabilities.
2021 - 2023
2021 - 2023
2021 - 2022
2021 - 2022
2021 - 2022
2021 - 2022
2021 - 2021
2021 - 2021
2018 - 2019
2018 - 2019
2017 - 2018
2017 - 2018
• Performed due diligence on investment candidates, including market dynamics, competitive landscape, and financial statements • Assisted potential candidates with go-to-market strategy, team creation and fundraising strategy